ReviewAdvances in pharmacology (San Diego, Calif.)2025
Neutral sphingomyelinase 2: A promising drug target for CNS disease.
Meixiang Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewAdvances in pharmacology (San Diego, Calif.)2025
Meixiang Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.